Johnson & Johnson (JNJ) Equity Average (2016 - 2025)
Historic Equity Average for Johnson & Johnson (JNJ) over the last 17 years, with Q3 2025 value amounting to $78.9 billion.
- Johnson & Johnson's Equity Average rose 1132.99% to $78.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $78.9 billion, marking a year-over-year increase of 1132.99%. This contributed to the annual value of $70.1 billion for FY2024, which is 365.03% down from last year.
- According to the latest figures from Q3 2025, Johnson & Johnson's Equity Average is $78.9 billion, which was up 1132.99% from $78.3 billion recorded in Q2 2025.
- In the past 5 years, Johnson & Johnson's Equity Average ranged from a high of $78.9 billion in Q3 2025 and a low of $63.9 billion during Q1 2021
- In the last 5 years, Johnson & Johnson's Equity Average had a median value of $72.9 billion in 2022 and averaged $72.2 billion.
- Per our database at Business Quant, Johnson & Johnson's Equity Average soared by 1519.61% in 2022 and then tumbled by 753.02% in 2023.
- Quarter analysis of 5 years shows Johnson & Johnson's Equity Average stood at $69.9 billion in 2021, then grew by 7.94% to $75.5 billion in 2022, then decreased by 7.26% to $70.0 billion in 2023, then grew by 1.18% to $70.8 billion in 2024, then grew by 11.37% to $78.9 billion in 2025.
- Its last three reported values are $78.9 billion in Q3 2025, $78.3 billion for Q2 2025, and $74.8 billion during Q1 2025.